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        A proper level of apoptosis is required for the 
maintenance of normal hematopoietic homeo-
stasis by removing aged or abnormal cells. The 
balance between proapoptotic and antiapop-
totic mechanisms is tightly controlled in hema-
topoietic cells, including hematopoietic stem 
cells (HSCs) and progenitor cells (HSC/Ps) by 
intrinsic signals that are subject to regulation by 
signals emanating from the BM microenviron-
ment (  1  –  3  ). Hematopoietic cytokines such as 
stem cell factor, IL-3, and thrombopoietin pro-
vide a survival signal for hematopoietic cells (  4, 5  ) 
by inducing the activation of PI3K/AKT (  6  ) 
and NF-    B (  7  ) signaling, and by up-regulating 
antiapoptotic genes, such as members of the 
Bcl2 family (  1  –  3  ). Proinfl  ammatory cytokines, 
including TNF-     (  8  ) and IL-1     (  9  ), as well as 
Fas ligand (  10  ), all mediate dual signals for 
HSC/P functions. A negative signal induces 
programmed cell death and/or diff  erentiation, 
whereas a positive signal promotes proliferation 
and survival. Disruption of this balance will re-
sult in hematopoietic disorders, including BM 
failure and leukemia (  1  –  3  ). 
  TGF-      –  activated kinase 1 (TAK1) is a key 
mediator of stress and proinfl  ammatory signals 
(  11  ). The proinfl  ammatory cytokines induce 
both proapoptotic and antiapoptotic signals 
in their target cells. TAK1 mediates the pro-
survival signal of the proinfl  ammatory cytokines 
by inducing the nuclear localization of NF-    B 
and the activation of c-Jun   N  -terminal kinases 
(JNKs)/AP1 (  11  ), whereas the proapoptotic sig-
nal is mediated by the activation of the caspase 
cascade (  12  ). Studies have demonstrated that 
TAK1-transduced signals from TCRs and B cell 
receptors, as well as antigen stimulation, play 
a role in T and B cell activation and survival, 
T regulatory cell development, and B cell  –
  mediated innate immunity (  13  –  16  ). The role of 
CORRESPONDENCE  
  J. Zhang:  
 jzhang@lumc.edu
  Abbreviations used: APC, al-
lophycocyanin; CP, committed 
hematopoietic progenitor; Hb, 
hemoglobin; HSC, hematopoi-
etic stem cell; HSC/P, HSC 
and progenitor cell; JNK, c-Jun 
  N  -terminal kinase; LK, 
lineage      Sca1      c-kit  +   cell; LSK, 
lineage      Sca1  +  c-kit  +   cell; plt, 
platelet number; polyI:C, poly-
inosinic:polycytidylic acid; 
TAK1, TGF-      –  activated kinase 1; 
TNC, total nucleated cell num-
ber; TUNEL, terminal deoxy-
nucleotidyltransferase-mediated 
UTP end-labeling; WBC, white 
blood cell. 
  M. Tang, X. Wei, and Y. Guo contributed equally 
to this paper. 
    X. Wei  ’  s present address is Henan Tumor Hospital, 127 
Dongming Road, Zhengzhou 450008, China. 
  Y. Guo  ’  s present address is Dept. of Respiratory and Molec-
ular Biology, Renji Hospital, Shanghai Jiaotong University 
School of Medicine, Shanghai 200127, China. 
    The online version of this article contains supplemental material.   
  TAK1 is required for the survival of 
hematopoietic cells and hepatocytes in mice 
    Minghui     Tang  ,    1       Xudong     Wei  ,    1      Yinshi     Guo  ,    1       Peter     Breslin  ,    1,3       Shubin     Zhang  ,    1     
  Shanshan     Zhang  ,    1       Wei     Wei  ,    1       Zhenbiao     Xia  ,    1       Manuel     Diaz  ,    1       Shizuo     Akira  ,    4     
and   Jiwang     Zhang      1,2     
  1  Oncology Institute, Cardinal Bernardin Cancer Center, and   2  Pathology Department, Loyola University Medical Center, 
Maywood, IL 60153 
  3  Department of Biology, Loyola University Chicago, Chicago, IL 60626 
  4  Department of Host Defense and Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology 
Agency, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan     
  Transforming growth factor       –  activated kinase 1 (TAK1), a member of the MAPKKK fam-
ily, is a key mediator of proinfl  ammatory and stress signals. Activation of TAK1 by proin-
fl  ammatory cytokines and T and B cell receptors induces the nuclear localization of nuclear 
factor     B (NF-    B) and the activation of c-Jun   N  -terminal kinase (JNK)/AP1 and P38, 
which play important roles in mediating infl  ammation, immune responses, T and B cell 
activation, and epithelial cell survival. Here, we report that TAK1 is critical for the survival 
of both hematopoietic cells and hepatocytes. Deletion of   TAK1   results in bone marrow (BM) 
and liver failure in mice due to the massive apoptotic death of hematopoietic cells and 
hepatocytes. Hematopoietic stem cells and progenitors were among those hematopoietic 
cells affected by TAK1 deletion  –  induced cell death. This apoptotic cell death is autono-
mous, as demonstrated by reciprocal BM transplantation. Deletion of   TAK1   resulted in the 
inactivation of both JNK and NF-    B signaling, as well as the down-regulation of expression 
of prosurvival genes. 1612 TAK1 IN HEMATOPOIETIC AND HEPATIC CELLS   | Tang et al. 
    RESULTS   
  TAK1 expression and activity in hematopoietic cells 
  To study whether TAK1 is involved in normal hematopoie-
sis, we fi  rst examined whether TAK1 is expressed in hemato-
poietic cells by using quantitative RT-PCR assays. TAK1 
knockout BM cells were used as a negative control. We 
found that TAK1 RNA is expressed in all lineages of 
hematopoietic cells, including HSCs (lineage       Sca1  +  c-kit  +   
cells [LSKs]), committed hematopoietic progenitors (CPs) 
(lineage       Sca1       c-kit  +   cells [LKs]), mature myeloid cells 
(Gr1  +  ), B cells (B220  +  ), B cell progenitors (B220  +  c-kit  +  ), 
nucleated erythroid cells (Ter119  +  ), and T cells (CD3  +  ). Its 
level of expression is also increased in progenitors including 
CPs and B cell progenitors (  Fig. 1 I  ).   Furthermore, by using 
a fl  ow cytometry  –  based intracellular protein detection assay, 
we found that the expression of TAK1 protein in c-kit  +   
HSC/Ps (including HSCs and CPs) and Gr1  +   myeloid cells 
was higher than that in B220  +   B cells (  Fig. 1, A  –  C  ); yet, 
TAK1 activity (indicated by p-TAK1 levels) (  20  ) is higher in 
TAK1 in hematopoiesis is still not fully understood. Although 
previous studies suggested that proinfl  ammatory  cytokines 
might play a negative role in hematopoiesis and contribute 
to some of the BM failure syndromes (  17, 18  ), recent stud-
ies demonstrate that HSC/Ps are resistant to proinfl  ammatory 
and stress signal  –  induced apoptosis (  10, 19  ). We propose that 
TAK1 is expressed and activated in hematopoietic cells, in-
cluding HSC/Ps, thus protecting them from apoptosis. 
  The TAK1-null phenotype is lethal early in embryonic 
development (  11, 13  ), impeding exploration of the role of 
TAK1 in adult hematopoiesis. To investigate whether TAK1 
plays a role in the regulation of normal hematopoietic homeo-
stasis, we generated inducible  TAK1   knockout mice. We found 
that inducing the deletion of   TAK1   in adult mice results in BM 
and liver failure due to massive cell-autonomous apoptotic 
death of hematopoietic cells, including HSC/Ps, and hepato-
cytes. Further study demonstrated that TAK1 mediates the sur-
vival signal in HSC/Ps via activation of JNK/AP1 and NF-    B 
signal pathways and up-regulation of survival gene expression. 
    Figure 1.           TAK1   is expressed and activated in hematopoietic cells, including HSC/Ps.   BM cells were collected into lyse/fi  x buffer immediately after 
the mice were killed to fi  x the BM cells and lyse the RBCs simultaneously. BM-nucleated cells were washed three times with PBS containing 5% FBS to 
completely remove all traces of the lyse/fi  x buffer. The cells were stained with cell surface markers as indicated and then permeabilized using permeabili-
zation buffer for TAK1 and p-TAK1 staining. (A  –  C) High level of TAK1 protein expression in c-kit  +   hematopoietic cells and Gr1  +   myeloid cells, but low ex-
pression in B220  +   B cells. (D  –  F) TAK activity (shown here by p-TAK1 levels) is higher in c-kit  +   hematopoietic cells (including B220  + c-kit +   B cell progenitors, 
red arrow in F). (G and H) No obvious difference in   TAK1   expression in LSK-HSC/Ps and LK-CPs, but increased TAK1 activity in LK-CPs compared with LSK-
HSC/Ps. (I)   TAK1   is expressed in all lineages of hematopoietic cells, including HSC/Ps, as shown by quantitative RT-PCR. BM cells from   TAK1   knockout  mice 
(4 d after mutation induction) were used as negative controls. Compared with differentiated cells, including Gr1  +   myeloid cells, B220  +   B cells, Ter119  + -
nucleated erythoid cells, and CD3  +   T cells,   TAK1   RNA expression was signifi  cantly higher in LK-CPs and B cell progenitors (B220  + c-kit +  ). Both * and ** 
are P   <   0.01. *, compared with   TAK1    /      BM cells; **, compared with mature hematopoietic cells, including Gr1  + ,  B220 +  , and CD3  +   cells.   JEM VOL. 205, July 7, 2008 
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by Cre-mediated recombination.   Mx1Cre   mice are an inter-
feron-inducible Cre mouse line in which Cre expression can 
be induced at any time after birth by injecting the mice with 
the interferon inducer polyinosinic:polycytidylic acid (polyI:
C) (  21  ). Mx1Cre-mediated recombination of loxp sites is 
very effi   cient in hematopoietic cells from the BM, spleen, 
and thymus, including HSC/Ps as well as liver cells (  21  ). 
By proper mating, we generated   TAK1      /       , heterozygous 
(  Mx1Cre  +  TAK1  fx/+    ,   TAK1  +/        hereafter), and WT control 
mice (  Mx1Cre       TAK1  fx/fx     or   Mx1Cre       TAK1  fx/+    , WT hereaf-
ter) in the same litter. Therefore, all of the   TAK1      /        mice 
analyzed had both   TAK  1  +/      and   WT   littermate controls. At 
6  –  8 wk of age, the mice (including   TAK1  +/        and   WT   con-
trols) were injected with polyI:C either once or three times 
(once every other day) to induce the   TAK1   deletion. To 
control for the possibility that polyI:C injection itself might 
c-kit  +   HSC/Ps than in diff  erentiated Gr1  +   myeloid cells and 
B220  +   B lymphocytes (  Fig. 1, D  –  F  ). We further separated 
HSCs and CPs by sca1 and c-kit staining followed by lineage 
depletion and found that, although TAK1 protein levels were 
comparable in HSCs and CPs, p-TAK1 levels were higher in 
CPs than in HSCs (  Fig. 1, G and H  ). Interestingly, we also 
found that among B220  +   cells, B cell progenitors displayed 
higher levels of TAK1 activity (  Fig. 1 F  ). 
  Generation of inducible TAK1      /      mice 
  To study whether TAK1 plays a role in hematopoiesis, we 
generated inducible   TAK1   knockout mice (  Mx1Cre  +  TAK1  fx/fx    , 
  TAK1      /        hereafter) by crossing   TAK1  fx/fx     mice with 
  Mx1Cre   mice. The second exon of the   TAK1   gene (which 
encodes the enzyme  ’  s catalytic domain) is fl  anked with two 
loxp sites in the   TAK1  fx/fx     mice (  13  ) and thus can be deleted 
    Figure 2.         Hepatocyte apoptosis and liver failure in   TAK1      /        mice.    TAK1    /      mice were killed on day 8 after the fi  rst polyI:C injection. (A) Both jaun-
dice and ascites were observed in   TAK1    /      mice. Livers of the   TAK1    /      mice were pale and jaundiced (left specimen, arrowhead) compared with   TAK1  +/     
control (right specimen, arrow). Nuclear condensation due to apoptosis was observed in   >  30  –  50% of hepatocytes of   TAK1    /      mice as shown by hema-
toxylin and eosin staining of liver sections (B), which is confi  rmed by TUNEL staining (D). Liver sections from   TAK1  +/      mice were used as controls. 
(C and E) Bars, 100   μ  m.     1614 TAK1 IN HEMATOPOIETIC AND HEPATIC CELLS   | Tang et al. 
notion, we observed that the   TAK1      /        recipient mice that 
received normal BM did not show any signs of bleeding but 
did show evidence of signifi  cant hepatocyte apoptosis (not 
depicted). These mice also died 8  –  10 d after their fi  rst polyI:C 
injection. This also suggests that the bleeding observed in the 
  TAK1      /        mice was not due to the liver defects and was not 
the cause of mortality. 
  BM failure in TAK1 knockout mice due to the apoptotic 
loss of hematopoietic cells 
  To investigate whether   TAK1   deletion aff  ects hematopoiesis, 
we fi  rst examined white blood cell (WBC) counts, platelet 
number (plt), RBC counts, and hemoglobin (Hb) concentra-
tions at 8 d after the fi  rst polyI:C injection. We found that 
both WBCs and plt were signifi   cantly reduced in the 
  TAK1      /        mice (  Fig. 3, A and B  ).   We believe that the de-
crease in plt counts was the reason for the bleeding seen in 
multiple organs in the  TAK1      /        mice because their plt counts 
were   <  200   ×   10  9  /ml. Human patients showing such severe 
thrombocytopenia typically present with severe bleeding. 
However, RBCs and Hb were slightly lower in   TAK1      /        
than in WT and   TAK1  +/        controls (not depicted). These 
data suggest that   TAK1      /        results in a pancytopenic eff  ect. 
aff  ect hematopoiesis, at least one mouse in each litter was 
maintained without injection and served as noninjected con-
trol. All mice were checked daily for phenotypic changes. 
  Liver failure in inducible TAK1 knockout mice 
due to increased hepatocyte apoptosis 
  We found that all the   TAK1      /        mice died within 8  –  10 d af-
ter the fi  rst polyI:C injection, regardless of whether they 
were injected once or three times; however, the   TAK1  +/        
mice showed no signifi  cant defects. By careful dissection of 
the mice, we found that all of the   TAK1      /        mice had both 
jaundice and ascites (  Fig. 2 A  ).   The livers of the knockout 
mice were relatively smaller and stiff  , and they appeared a 
pale, jaundiced color. Destruction of normal liver histological 
structure was evident upon microscopic analysis. The nuclei 
of   >  30  –  50% of the hepatocytes were condensed because of 
apoptosis, which was demonstrated by terminal deoxynucle-
otidyltransferase-mediated UTP end-labeling (TUNEL) 
staining (  Fig. 2, B  –  E  ). Although,   >  30% of the mice showed 
intestinal, urinary bladder, and/or gallbladder hemorrhaging 
(not depicted), we believe that acute liver failure, as a conse-
quence of massive hepatocyte apoptosis, was the major cause 
of mortality among the   TAK1      /        mice. In support of this 
    Figure 3.         Pancytopenia and BM failure in   TAK1      /        mice.   Peripheral blood, BM, spleens, and thymuses were collected on day 8 after the fi  rst polyI:C 
injection. WBC count (A), plt in peripheral blood (B), and nucleated cell number in the BM (C), spleen (D), and thymus (E) were measured in   TAK1    /    , 
  TAK1  +/     , and WT mice, as well as in noninjected control mice. BM sections from   TAK1  +/      (F) and   TAK1    /      (G) mice at day 8 after the fi  rst polyI:C injection 
were stained with hematoxylin and eosin. BM sections from TAK1  +/      (H) and TAK1     /     (I) mice at day 4 after the fi  rst polyI:C injection were stained with 
TUNEL to display the apoptotic cells (indicated by red color staining). Bars, 100   μ  m. *, P   <   0.05; **, P   <   0.01.     JEM VOL. 205, July 7, 2008 
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mus, which was 1/20 to 1/100 of the number of TNCs ob-
tained from each control mouse thymus. 
  Histological sectioning showed that BM from   TAK1      /        
mice was hypocellular and BM structure was destroyed, simi-
lar to the myelodepletion phenotype seen in mice after high-
dose chemotherapy or irradiation (  Fig. 3, E and G  ). These 
data suggest that the   TAK1      /        mice had BM failure. In situ 
TUNEL staining demonstrated that the BM failure of the 
  TAK1      /        mice was due to the massive apoptotic death of 
hematopoietic cells (  Fig. 3 I  ). 
  Because no signifi  cant diff  erence was observed between 
  TAK  +/        and WT mice, and similar to   TAK1      /        mice, 
  TAK1  +/        mice also express Cre after polyI:C injection, we 
considered   TAK1  +/        mice to be better controls than WT 
mice. Therefore we used   TAK1  +/        mice as controls in most 
of our subsequent studies. 
  HSC/Ps are among those hematopoietic cells affected 
by TAK1 deletion  –  induced apoptosis in TAK1      /      mice 
  To investigate whether HSC/Ps were aff  ected in   TAK1      /        
mice, we fi  rst examined HSC/P numbers by cell surface 
marker staining and fl  ow cytometric analysis. We found that 
both LSK-HSCs and LK-CPs were signifi  cantly reduced in 
  TAK1      /        mice (  Fig. 4, A  –  D  ).   The obvious reduction in 
HSCs and CPs could be observed at day 4 after the fi  rst dose 
of polyI:C injection (  Fig. 4 B  ). There were almost no HSCs 
nor CPs detectable at day 8. The reduction in HSC/Ps in 
  TAK1        /      mice was confi  rmed by CFU assay (  Fig. 4 E  ). We 
found that the CFU number (counted at day 12 after seeding, 
which refl  ects the number of functional HSC/Ps) was signifi  -
cantly reduced in   TAK1      /        BM. Upon further analysis using 
annexin V staining, we found a three- to fi  vefold increase in 
apoptosis (shown as annexin V  +  ) in the c-kit  +   population 
(consisting of HSCs and CPs) from   TAK1      /        mice compared 
  To study whether the pancytopenia in   TAK1      /        mice 
was due to BM hematopoietic defects, we collected BM, 
spleens, and thymuses from   TAK1      /        and control mice at 
day 8 after the fi  rst polyI:C injection. The total nucleated 
cell number (TNC) of BM, spleens, and thymuses were ana-
lyzed. We found that the TNC of BM, spleens, and thymuses 
was signifi  cantly decreased in   TAK1      /        mice compared with 
  TAK1  +/        and WT control mice, as well as noninjected 
control mice (  Fig. 3, C  –  E  , and Fig. S1, which is available at 
http://www.jem.org/cgi/content/full/jem.20080297/DC1). 
Although the TNCs in the BM, spleens, and thymuses in 
the polyI:C-injected groups were more diverse from mouse 
to mouse, shown by the relatively larger standard deviations, 
no signifi  cant diff  erences were observed between   TAK1  +/      
and WT, the latter being comparable to noninjected con-
trol mice. This indicates that heterozygous   TAK1   deletion 
did not aff  ect hematopoiesis in the mice. It also suggests that 
polyI:C injection itself likely contributes negligibly to the 
phenotypes we observed in the   TAK1      /        mice. This notion 
was supported by cell surface staining and fl  ow cytometric 
analysis. We found that there were no signifi  cant diff  erences 
among   TAK1  +/       , WT, and noninjected control mice in the 
percentage of myeloid cells and T and B lymphocytes in 
all hematopoietic tissues examined including the peripheral 
blood, BM, and spleen. However, in   TAK1      /        mice, sig-
nifi  cant increases in T cell percentage were consistently ob-
served in the peripheral blood, BM, and spleen (the absolute 
T cell number in all these tissues was still dramatically lower 
than controls; Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20080297/DC1). We believe that the in-
crease in T cell percentage in the   TAK1      /        mice has noth-
ing to do with thymic T cell production because the thymus 
gland in   TAK1      /        mice was very small. Only 1  –  4   ×   10  6   
TNCs could be obtained from each   TAK1      /        mouse thy-
    Figure 4.         HSC/Ps are affected by   TAK1   deletion  –  induced apoptotic cell death in   TAK1      /        mice.   BM was collected from   TAK1  +/      and   TAK1    /     
mice on days 4, 6, and 8 after the fi  rst polyI:C injection. After lysis of RBCs, BM-nucleated cells were stained with cell surface markers and analyzed by 
fl  ow cytometry for HSCs and CPs. Progressive loss of HSCs and CPs in   TAK1    /      mouse BM is shown by lineage marker and Sca1 c-kit staining (B  –  D). 
Day 8   TAK1  +/      BM cells were used as a control (A). (E) Progressive reduction of colony-forming ability of   TAK1    /      BM cells after   TAK1   deletion. (F) BM 
cells were collected from   TAK1    /      and   TAK1  +/      mice 16 h after a single polyI:C injection, and apoptosis was checked by annexin V staining. *, P   <   0.05; 
**,  P   <   0.01.   1616 TAK1 IN HEMATOPOIETIC AND HEPATIC CELLS   | Tang et al. 
the recipients were given three polyI:C injections, once ev-
ery other day, and the livers, peripheral blood, spleens, and 
BM were harvested for analysis on day 8 after the last injec-
tion. We found signifi  cant apoptosis of hepatocytes in all 
  TAK1      /        recipients (not depicted). However, the normal 
BM hematopoiesis in   TAK1      /        recipients suggested that the 
  TAK1   deletion BM microenvironment has a normalizing 
hematopoietic supportive function (  Fig. 5, C and D  ). Con-
sistent with this observation, we found that plt counts and Hb 
concentrations in the   TAK1      /        recipients were comparable 
to those of the   TAK1  +/        recipients (  Fig. 5, E  –  H  ). Further-
more, we found that the livers of the   TAK1      /        recipients 
that had received WT BM had obvious myeloid cell infi  ltra-
tion (not depicted). The WBC counts, neutrophil percent-
ages, and neutrophil/lymphocyte ratios were signifi  cantly 
increased in the   TAK1      /        recipients compared with the 
  TAK1  +/        recipients (  Fig. 5 E   and not depicted). We believe 
that the increase in WBC counts and neutrophils as well as 
the myeloid infi  ltration of liver tissue in the   TAK1      /        recip-
ients were due to infl  ammatory reactions induced by hepato-
cyte apoptosis. 
    DISCUSSION   
  TAK1 was originally identifi  ed as a key regulator of TGF-    /
bone morphogenic protein signals (  23  ). It is known to play 
an important role in early embryonic development (  13  ). 
  TAK1  -null mice die at embryonic day 11.5 with signifi  cant 
with control mice at 16 h after a single polyI:C injection. 
Upon further analysis by separating HSCs from CPs within 
the c-kit  +   population, we found apoptosis among both of 
these cell types to be signifi  cantly increased (  Fig. 4 F  ) com-
pared with such cells taken from control mice. 
  Hematopoietic cells of TAK1      /      mice show intrinsic defects 
  Previously, we have found that Mx1Cre can mediate gene 
deletion in both hematopoietic and BM stromal cells (  22  ). 
To address whether the defects of hematopoietic cells in 
  TAK1      /        mice were intrinsic to the cells, reciprocal BM 
transplantations were performed. We transplanted   TAK1      /        
BM cells (before deletion was induced) into lethally irradi-
ated syngeneic WT recipients. Because in these mice the BM 
microenvironment is normal, we were able to test the func-
tion of   TAK1      /        hematopoietic cells within this normal BM 
microenvironment. 1 mo after transplantation, the recipients 
received polyI:C injections every other day for a total of 
three injections and were killed for analysis on day 8 after the 
fi  rst injection. We found pancytopenia and BM failure in 
the recipients that had received the   TAK1      /        BM; however, the 
  TAK1  +/        BM recipients were normal (  Fig. 5, A, B, and E  –  H  ).   
This suggests that the hematopoietic cells from   TAK1      /        
mice have cell-intrinsic defects that prohibit their survival in 
a normal BM microenvironment. We also transplanted BM 
from WT mice into the lethally irradiated   TAK1      /        recipi-
ents (before deletion induction). 1 mo after transplantation, 
    Figure 5.         Cell-autonomous defects of   TAK1      /        HSC/Ps.   Reciprocal transplantation assay was performed by transplantation of   TAK1    /      BM  (before 
mutation was induced) into lethally irradiated WT mice (A) and, reciprocally, WT BM into lethally irradiated   TAK1    /      mice (before mutation was induced; C). 
  TAK1   deletion was induced 1 mo after transplantation by injecting the recipient mice with polyI:C every other day for a total of three injections.   TAK1  +/     
mice were used as respective controls in this experiment (B and D). On day 8 after the fi  rst polyI:C injection, recipient mice were killed for analysis. BM 
sections from the recipients showed that   TAK1    /      HSC/Ps failed to grow in the WT BM environment (A), whereas the   TAK1    /      BM microenvironment was 
able to support the growth of WT HSC/Ps (C). (E  –  H) Signifi  cant reduction of WBC counts and plt in peripheral blood, and nucleated cells in the BM and 
spleen in WT recipients that received   TAK1    /      BM. (E) Obvious increase in WBC counts in   TAK1    /      recipients that received WT BM. (I and J) Equal numbers 
of   TAK1    /      BM cells (CD45.2  +  , before mutation was induced) were mixed with WT (CD45.1  +  ) BM cells and transplanted into lethally irradiated WT 
(CD45.1  +  ) recipients. 6 wk after transplantation,   TAK1   mutation was induced by injecting the recipient mice with polyI:C every other day for a total of 
three injections.   TAK1  +/      BM cells were transplanted in parallel as a control. The contribution of the   TAK1    /      BM HSC/Ps to hematopoiesis in the recipient 
mice (shown as CD45.2  +   percentage in peripheral blood) was signifi  cantly lower than that of control BM HSC/Ps. Data shown in I and J were analyzed on 
day 15 after the fi  rst polyI:C injection. *, P   <   0.05; **, P   <   0.01.     JEM VOL. 205, July 7, 2008 
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  Studies using tissue-specifi  c   TAK1   knockout mice have 
demonstrated that TAK1, mediating B cell receptor signaling 
and antigen responses in B cells and TCR signaling in T cells, 
is essential for B cell  –  mediated innate immunity and both 
peripheral T cell and T-regular cell activation, survival, and 
function (  13  –  16  ). However, in these knockout mice, signifi  -
cant reductions of nucleated cells in the thymus and of B cells 
in the BM and spleen were not observed (  13  –  16  ). In our in-
ducible   TAK1      /        mice, we found signifi  cant reductions in 
the numbers of all lineages of hematopoietic cells, including 
myeloid cells and B cells and T cells in the spleen and BM. 
We also found a dramatic reduction in thymus size due to 
decreased numbers of thymocytes (  Fig. 3  ). We speculate that 
c-kit  +   progenitors might possibly rely more on TAK1 for 
their survival, and that these were not targeted in the B cell  –   
and T cell  –  specifi  c knockout mice. In support of this idea, 
our data showed higher TAK1 activity in HSC/Ps and B cell 
progenitors than mature myeloid and B cells. But further 
study will be needed to establish this defi  nitively. Whether 
cells with higher TAK1 activity are more sensitive to   TAK1   
deletion  –  induced apoptosis than cells with lower TAK1 ac-
tivity will require further detailed investigation. 
  Both JNK and NF-    B have been found to be activated in 
many malignant disorders and infl  ammatory diseases (  29, 30  ). 
We predict that TAK1, which is upstream of JNK and NF-
    B, might also be involved in these disorders. Further study 
may also reveal whether the BM failure phenotype seen in 
our   TAK1      /        mice might also be involved in some BM fail-
ure syndromes such as aplastic anemia. Further examination 
of   TAK1   expression profi  les and activities in clinical samples 
could be expected to provide new insights into the important 
roles TAK1 might play in these diseases. 
  MATERIALS AND METHODS 
  Generation of inducible   TAK1   knockout (  TAK1      /       ) mice.       TAK1  fx/fx     
mice were described previously (  13  ). Exon-2 of the   TAK1   gene was fl  anked 
by two loxp sites.   Mx1Cre   mice were purchased from JAX Laboratories (  21  ). 
All mice were maintained according to the standards set forth in the National 
Institutes of Health Guidelines for the Care and Use of Animals in the animal 
facility at Loyola University Medical Center in a CD57B6 background. All 
experiments performed on animals were approved in advance by Loyola 
University Institutional Animal Care and Use Committee (protocol no. 
108832). By crossing   Mx1Cre   mice with   TAK1  fx/fx     mice and then backcross-
ing, we generated interferon-inducible   TAK1   knockout mice, including 
  TAK1      /       ,   TAK1  +/        (heterozygous,   Mx1Cre  +  TAK1  fx/+    ) and WT (WT, 
  MX1Cre       TAK1  fx/fx     or   MX1Cre       TAK1  fx/+    ) animals in the same litter, so that 
all the   TAK1      /        mice analyzed had proper controls. 6  –  8 wk after birth, one 
mouse from each litter was maintained without injection as noninjected 
control, and all other mice, including   TAK1  +/        and WT controls, were in-
jected with 5   μ  g/g body weight of polyI:C for either a single injection or 
every other day for a total of three injections to induce   TAK1   deletions. 
  Mouse hematopoietic phenotype analysis.     Mice were killed at the 
indicated time points to collect peripheral blood, spleen, thymus, and BM. 
Peripheral blood was analyzed for WBC counts, plt, RBC counts, and Hb 
concentration by using Hemavet 950FS (Drew Scientifi  c Inc.). After lysis of 
RBCs, nucleated cells from peripheral blood, spleen, thymus, and BM were 
counted and further stained with cell surface markers for phenotype analysis 
by using fl  ow cytometry as described previously (  22  ). All the fl  uorescent anti-
bodies used in fl  ow cytometric analysis were purchased from eBioscience. 
vascular defects, reminiscent of the mouse phenotype in 
which the TGF-    1 receptors ALK-1 and endoglin have been 
knocked out. Moreover,   TAK1   overexpression can compen-
sate for the TGF    1 receptor knockout phenotype (  24  ). 
However, in vitro biochemical and in vivo genetic studies 
suggest that TAK1 is also a signifi  cant mediator of infl  amma-
tory cytokine signals (  11  ). 
  Mouse embryonic fi  broblasts from   TAK1  -null mice ex-
hibit dramatically impaired NF-    B and JNK activation 
through TNFR-1, IL-1R, and Toll-like receptors. These cells 
are also highly sensitive to TNF-      –  induced apoptosis (  11  ). 
TAK1 has also been found to be critical for keratinocyte 
survival. Keratinocytes with   TAK1   deletions are inactivated 
for NF-    B and JNK, and are sensitive to TNF-      –  induced 
apoptosis (  25  ). 
  Our data suggest that TAK1 might mediate a general sur-
vival signal for many tissue cells, although the sensitivity of dif-
ferent types of cells to   TAK1   deletion varies. In our inducible 
TAK1 knockout mice, massive apoptotic cell death was ob-
served in hematopoietic cells in the BM, spleen, and thymus, 
as well as in hepatocytes, where Cre-mediated   TAK1   deletion 
occurred. We also found that in hematopoietic cells and hepa-
tocytes, TAK1 stimulated a survival signal also mediated by 
up-regulating the expression of survival genes via the IKK      –
  NF-    B and JNK  –  AP1 signaling pathways (not depicted). 
  It has been reported that NF-   B mediates a very important 
survival signal to protect cells from TNF-      –  induced apop-
tosis. Inactivation of NF-    B by gene mutation or pharma-
cological inhibition sensitizes such cells to TNF-      –  induced 
apoptosis. However, NF-    B knockout mice (Mx1Cre-me-
diated polyI:C-inducible knockout, the same system we used 
in our present studies) developed normally under normal 
husbandry without diff  erences in gross anatomy, histologi-
cal organization, or hepatic function (  26  ). In contrast to the 
acute liver failure of   TAK1      /        mice, the syndrome of hepatic 
failure resulting from hepatocyte apoptosis seen in NF-    B 
knockout mice occurred only when the mice were treated 
with TNF-     (  26  ). Moreover, as opposed to the BM failure 
phenotype of our   TAK1      /        mice, which was secondary to 
cell-autonomous apoptosis, the mice with IKK    /NF-    B sig-
nal inactivation showed stress-related B and T cell depletion, 
whereas HSC/Ps remained unaff  ected in this condition (  27  ). 
In fact, the myeloid cells of NF-    B  –  inactivated mice show 
a high proliferative index and multiple tissue infl  ammation 
reactions due to autocrine secretion of infl  ammatory cyto-
kines (such as TNF-    ) (  27  ). This suggests that IKK    /NF-    B 
signaling is not essential for the survival of HSC/Ps and my-
eloid cells. 
  In   TAK1      /        HSC/Ps, in addition to the inactivation of 
NF-    B signals, JNK signals were also inactivated. The role of 
JNK signaling is cell context dependent. Both proapoptotic 
and prosurvival eff  ects of JNK signals have been reported 
(  28  ). The role of JNK in HSC/Ps has not yet been addressed. 
We predict that both JNK and NF-    B signals are required 
for HSC/P survival in mice. This needs to be further con-
fi  rmed by conditional compound knockout mouse studies. 1618 TAK1 IN HEMATOPOIETIC AND HEPATIC CELLS   | Tang et al. 
  Online supplemental material.     Fig. S1 shows reduction of BM-nucle-
ated cell numbers in   TAK1      /        mice after the induction of   TAK1   deletion. 
Fig. S2 shows analyses of the percentage of mature hematopoietic cells in the 
  TAK1      /        and littermate control mice. Figs. S1 and S2 are available at http://
www.jem.org/cgi/content/full/jem.20080297/DC1. 
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